The unique gene that was found in all cancer and oral potentially malignant disorders was EPRS (glutamyl-prolyl-tRNA synthetase 1), with a fold change of 0.653 (C vs N), 0.492 (F vs N) and 0.091 (L vs N) (Supplement 4). This evidence concerns the gene EPRS1 and cancer.